최소 단어 이상 선택하여야 합니다.
최대 10 단어까지만 선택 가능합니다.
다음과 같은 기능을 한번의 로그인으로 사용 할 수 있습니다.
NTIS 바로가기Scientific reports, v.11 no.1, 2021년, pp.500 -
Nagar, Harsha (Department of Medical Science, Chungnam National University, Daejeon, Republic of Korea) , Kim, Sungmin (Department of Medical Science, Chungnam National University, Daejeon, Republic of Korea) , Lee, Ikjun (Department of Medical Science, Chungnam National University, Daejeon, Republic of Korea) , Kim, Seonhee (Department of Medical Science, Chungnam National University, Daejeon, Republic of Korea) , Choi, Su-Jeong (Department of Medical Science, Chungnam National University, Daejeon, Republic of Korea) , Piao, Shuyu (Department of Medical Science, Chungnam National University, Daejeon, Republic of Korea) , Jeon, Byeong Hwa (Department of Medical Science, Chungnam National University, Daejeon, Republic of Korea) , Oh, Sang-Ha (Department of Plastic and Reconstructive Surgery, School of Medicine, Chungnam National University, 282 Munhwa-ro, Jung-Gu, Daejeon, 35015 Republic of Korea) , Kim, Cuk-Seong (Department of Medical Science, Chungnam National University, Daejeon, Republic of Korea)
Keloids are a type of aberrant skin scarring characterized by excessive accumulation of collagen and extracellular matrix (ECM), arising from uncontrolled wound healing responses. While typically non-pathogenic, keloids are occasionally regarded as a form of benign tumor. CR6-interacting factor 1 (C...
1. Li S Liu W Lei Y Long J Regulatory effects of electronic beam irradiation on mir-21/smad7-mediated collagen I synthesis in keloid-derived fibroblasts Biol. Open 2016 5 1567 1574 10.1242/bio.018770 27694104
2. Dong X Zhang C Ma S Wen H Mast cell chymase in keloid induces profibrotic response via transforming growth factor-beta1/Smad activation in keloid fibroblasts Int. J. Clin. Exp. Pathol. 2014 7 3596 3607 25120737
3. Butler PD Longaker MT Yang GP Current progress in keloid research and treatment J. Am. Coll. Surg. 2008 206 731 741 10.1016/j.jamcollsurg.2007.12.001 18387480
4. Seifert O Mrowietz U Keloid scarring: Bench and bedside Arch. Dermatol. Res. 2009 301 259 272 10.1007/s00403-009-0952-8 19360429
5. Shih B Garside E McGrouther DA Bayat A Molecular dissection of abnormal wound healing processes resulting in keloid disease Wound Repair Regen. 2010 18 139 153 10.1111/j.1524-475X.2009.00553.x 20002895
6. Sandulache VC Parekh A Li-Korotky H Dohar JE Hebda PA Prostaglandin E2 inhibition of keloid fibroblast migration, contraction, and transforming growth factor (TGF)-beta1-induced collagen synthesis Wound Repair Regen. 2007 15 122 133 10.1111/j.1524-475X.2006.00193.x 17244328
7. Xia W Longaker MT Yang GP P38 MAP kinase mediates transforming growth factor-beta2 transcription in human keloid fibroblasts Am. J. Physiol. Regul. Integr. Comp. Physiol. 2006 290 R501 R508 10.1152/ajpregu.00472.2005 16467496
8. Chin GS Differential expression of transforming growth factor-beta receptors I and II and activation of Smad 3 in keloid fibroblasts Plast. Reconstr. Surg. 2001 108 423 429 10.1097/00006534-200108000-00022 11496185
9. Berman B Maderal A Raphael B Keloids and hypertrophic scars: Pathophysiology, classification, and treatment Dermatol. Surg. 2017 43 Suppl 1 S3 S18 10.1097/DSS.0000000000000819 27347634
10. Chung HK CR6-interacting factor 1 interacts with Gadd45 family proteins and modulates the cell cycle J. Biol. Chem. 2003 278 28079 28088 10.1074/jbc.M212835200 12716909
11. Park KC CR6-interacting factor 1 interacts with orphan nuclear receptor Nur77 and inhibits its transactivation Mol. Endocrinol. 2005 19 12 24 10.1210/me.2004-0107 15459248
12. Kwon MC Crif1 is a novel transcriptional coactivator of STAT3 EMBO J. 2008 27 642 653 10.1038/sj.emboj.7601986 18200042
13. Kim SJ CRIF1 is essential for the synthesis and insertion of oxidative phosphorylation polypeptides in the mammalian mitochondrial membrane Cell Metab. 2012 16 274 283 10.1016/j.cmet.2012.06.012 22819524
14. Nagar H CR6-interacting factor 1 deficiency impairs vascular function by inhibiting the Sirt1-endothelial nitric oxide synthase pathway Antioxid. Redox Signal 2017 27 234 249 10.1089/ars.2016.6719 28117598
15. Vincent AS Human skin keloid fibroblasts display bioenergetics of cancer cells J. Investig. Dermatol. 2008 128 702 709 10.1038/sj.jid.5701107 17943178
16. Russell SB Trupin KM Rodriguez-Eaton S Russell JD Trupin JS Reduced growth-factor requirement of keloid-derived fibroblasts may account for tumor growth Proc. Natl. Acad. Sci. U.S.A. 1988 85 587 591 10.1073/pnas.85.2.587 3422443
17. Witt E Maliri A McGrouther DA Bayat A RAC activity in keloid disease: Comparative analysis of fibroblasts from margin of keloid to its surrounding normal skin Eplasty 2008 8 e19 18463712
18. Al-Attar A Mess S Thomassen JM Kauffman CL Davison SP Keloid pathogenesis and treatment Plast. Reconstr. Surg. 2006 117 286 300 10.1097/01.prs.0000195073.73580.46 16404281
19. Bock O Mrowietz U Keloids. A fibroproliferative disorder of unknown etiology Hautarzt 2002 53 515 523 10.1007/s00105-001-0316-6 12221465
20. Satish L Babu M Tran KT Hebda PA Wells A Keloid fibroblast responsiveness to epidermal growth factor and activation of downstream intracellular signaling pathways Wound Repair Regen. 2004 12 183 192 10.1111/j.1067-1927.2004.012111.x 15086770
21. Fujiwara M Muragaki Y Ooshima A Keloid-derived fibroblasts show increased secretion of factors involved in collagen turnover and depend on matrix metalloproteinase for migration Br. J. Dermatol. 2005 153 295 300 10.1111/j.1365-2133.2005.06698.x 16086739
22. Nedelec B Shankowsky H Scott PG Ghahary A Tredget EE Myofibroblasts and apoptosis in human hypertrophic scars: The effect of interferon-alpha2b Surgery 2001 130 798 808 10.1067/msy.2001.116453 11685189
23. Dong X Mao S Wen H Upregulation of proinflammatory genes in skin lesions may be the cause of keloid formation (review) Biomed. Rep. 2013 1 833 836 10.3892/br.2013.169 24649037
24. Vyas S Zaganjor E Haigis MC Mitochondria and cancer Cell 2016 166 555 566 10.1016/j.cell.2016.07.002 27471965
25. Attisano L Wrana JL Signal transduction by the TGF-beta superfamily Science 2002 296 1646 1647 10.1126/science.1071809 12040180
26. Inman GJ Linking Smads and transcriptional activation Biochem. J. 2005 386 e1 e3 10.1042/BJ20042133 15702493
27. Hayashi H The MAD-related protein Smad7 associates with the TGFbeta receptor and functions as an antagonist of TGFbeta signaling Cell 1997 89 1165 1173 10.1016/S0092-8674(00)80303-7 9215638
28. Nakao A Identification of Smad7, a TGFbeta-inducible antagonist of TGF-beta signalling Nature 1997 389 631 635 10.1038/39369 9335507
29. Briones-Orta MA Tecalco-Cruz AC Sosa-Garrocho M Caligaris C Macias-Silva M Inhibitory Smad7: Emerging roles in health and disease Curr. Mol. Pharmacol. 2011 4 141 153 10.2174/1874467211104020141 21222648
30. Yu H Bock O Bayat A Ferguson MW Mrowietz U Decreased expression of inhibitory SMAD6 and SMAD7 in keloid scarring J. Plast. Reconstr. Aesthet. Surg. 2006 59 221 229 10.1016/j.bjps.2005.06.010 16676428
31. Zhou R Wang C Wen C Wang D miR-21 promotes collagen production in keloid via Smad7 Burns 2017 43 555 561 10.1016/j.burns.2016.09.013 27717618
32. Gandhi NS Tekade RK Chougule MB Nanocarrier mediated delivery of siRNA/miRNA in combination with chemotherapeutic agents for cancer therapy: Current progress and advances J. Control Release 2014 194 238 256 10.1016/j.jconrel.2014.09.001 25204288
33. Pauley KM Cha S RNAi therapeutics in autoimmune disease Pharmaceuticals (Basel) 2013 6 287 294 10.3390/ph6030287 24276020
34. Khavari PA Rollman O Vahlquist A Cutaneous gene transfer for skin and systemic diseases J. Intern. Med. 2002 252 1 10 10.1046/j.1365-2796.2002.00995.x 12074732
35. Aldawsari M Chougule MB Babu RJ Progress in topical siRNA delivery approaches for skin disorders Curr. Pharm. Des. 2015 21 4594 4605 10.2174/1381612821666150911093606 26362644
36. Chen M Topical delivery of siRNA into skin using SPACE-peptide carriers J. Control Release 2014 179 33 41 10.1016/j.jconrel.2014.01.006 24434423
37. Liang X Skin delivery of siRNA using sponge spicules in combination with cationic flexible liposomes Mol. Ther. Nucleic Acids 2020 20 639 648 10.1016/j.omtn.2020.04.003 32380414
38. Marttala J Andrews JP Rosenbloom J Uitto J Keloids: Animal models and pathologic equivalents to study tissue fibrosis Matrix Biol. 2016 51 47 54 10.1016/j.matbio.2016.01.014 26827712
39. Seo BF Lee JY Jung SN Models of abnormal scarring Biomed. Res. Int. 2013 2013 423147 10.1155/2013/423147 24078916
해당 논문의 주제분야에서 활용도가 높은 상위 5개 콘텐츠를 보여줍니다.
더보기 버튼을 클릭하시면 더 많은 관련자료를 살펴볼 수 있습니다.
*원문 PDF 파일 및 링크정보가 존재하지 않을 경우 KISTI DDS 시스템에서 제공하는 원문복사서비스를 사용할 수 있습니다.
오픈액세스 학술지에 출판된 논문
※ AI-Helper는 부적절한 답변을 할 수 있습니다.